A coalition of doctors, human rights groups, and campaigners is calling on NHS hospitals to reconsider using the NHS Federated Data Platform (FDP) developed by US tech company Palantir, which is owned by Peter Thiel, a close ally of US President Donald Trump.
The FDP is a system created to consolidate information from various sources within the health service to facilitate analysis and improve the delivery of care.
While supporters argue that the technology is enhancing patient treatment and service management within the NHS, critics raise concerns about privacy, ethics, and the involvement of large tech companies in handling sensitive public sector data.
The FDP aims to integrate operational data from across the NHS, including waiting lists, hospital capacity, and patient pathways, to assist in care planning and resource allocation.
In 2023, Palantir was awarded a contract by NHS England for the platform, valued at up to £330m. The company claims that its technology is already enhancing the functioning of the service.
A 2023 protest against the NHS-Palantir contract outside NHS England’s headquarters in central London. File pic: PA
However, the contract has faced strong backlash from healthcare workers and groups like Medact, who have released a briefing calling for NHS entities to reconsider the adoption of the platform.
Dr. Rhiannon Mihranian Osborne is advocating for the cancellation of the contract, emphasizing the importance of privacy and ethics in patient care.
She expressed concerns about Palantir’s involvement in the scheme, stating that it could erode trust in the health system.
Palantir co-founder & CEO Alex Karp in 2023. File pic: Reuters
She called on local hospitals to reject Palantir software and prioritize the interests of patients and workers over big tech corporations.
She highlighted concerns about the software implementation, stating that NHS analysts have found it lacking, with escalating costs and the potential displacement of trusted local data solutions.
The debate has also attracted the attention of international human rights organizations.
Read more:
Bahrain and Saudi Arabia F1 races both scrapped
What future do you want for Sycamore Gap tree?
Matt Mahmoudi from Amnesty International, specializing in artificial intelligence and human rights, criticized Palantir’s track record of disregarding international law and standards, urging public institutions to reconsider working with the company.
Health officials view the system as part of broader efforts to modernize the NHS and utilize data more effectively to meet demand and enhance patient outcomes.
Health workers protesting outside the London headquarters of Palantir in 2023.
NHS hospitals are being urged by a group of doctors, human rights groups, and campaigners to reconsider using a major data platform built by US tech giant Palantir, whose owners include Peter Thiel, a close ally of US President Donald Trump.
The NHS Federated Data Platform (FDP) is a system designed to bring together information from across the health service so hospitals can analyze it more easily and improve how care is delivered.
Supporters say the technology is already helping the NHS treat more patients and manage pressure on services, but critics argue it raises wider concerns about privacy, ethics, and the role of large technology companies in handling sensitive public sector data.
Peter Thiel (centre) with Donald Trump in 2016. File pic: AP
The FDP aims to connect operational data from across the NHS, including information about waiting lists, hospital capacity, and patient pathways, allowing staff to plan care and allocate resources more effectively.
In 2023, NHS England awarded Palantir the contract for the platform worth up to £330m. The company says its technology is already improving how the service functions.
A 2023 protest against the NHS-Palantir contract outside NHS England’s headquarters in central London. File pic: PA
However, the deal has been strongly criticized by some healthcare workers and campaign groups like Medact, who have published a briefing urging NHS bodies to reconsider adopting the platform.
Dr Rhiannon Mihranian Osborne wants the contract to be scrapped and has told Sky News that staff understand the importance of privacy and ethics in patient care.
She said they are «horrified» by Palantir’s involvement in the scheme as it «could seriously damage trust in our health system».
Palantir co-founder & CEO Alex Karp in 2023. File pic: Reuters
NHS hospitals are being urged by a group of doctors, human rights groups and campaigners to reconsider using a major data platform built by US tech giant Palantir, whose owners include Peter Thiel, a close ally of US President Donald Trump. The NHS Federated Data Platform (FDP) is a system designed to bring together information from across the health service so hospitals can analyze it more easily and improve how care is delivered.
Supporters say the technology is already helping the NHS treat more patients and manage pressure on services, but critics argue it raises wider concerns about privacy, ethics, and the role of large technology companies in handling sensitive public sector data.
The FDP aims to connect operational data from across the NHS, including information about waiting lists, hospital capacity, and patient pathways, allowing staff to plan care and allocate resources more effectively. In 2023, NHS England awarded Palantir the contract for the platform worth up to £330m. The company says its technology is already improving how the service functions.
She urged local hospitals not to adopt Palantir software and, in doing so, «put the interests of patients and workers above American big tech corporations.» She said: «We know the rollout isn’t going to plan – NHS analysts have told us the software offers nothing special, implementation costs are spiraling and the drive to adopt Palantir tech risks pushing out local, trusted data solutions.» The debate has also drawn in international human rights organizations.
Matt Mahmoudi, a researcher and adviser on artificial intelligence and human rights at Amnesty International, said the company «has a track record of flagrantly disregarding international law and standards, both in the violations of the human rights of migrants in the United States, which it risks contributing to, and its ongoing supply of artificial intelligence products and services to the Israeli military and intelligence services.» Amnesty has asked public institutions to reconsider working with the company, Mr. Mahmoudi said.
Health officials say the system is part of a broader push to modernize the NHS and make better use of data to manage demand and improve outcomes for patients.
Palantir told Sky News its software «is playing an important role in improving patient care – helping to deliver 100,000 additional operations, a 12% reduction in discharge delays, and the removal of 675,000 patients from waiting lists.» It’s up to the NHS to decide how its products are used, the statement said, and data can only be processed «in accordance with their strict instructions.» The firm said it has «no intention of and no means of using the data in the way that the Medact report is suggesting, [as] to do so would be illegal and in breach of contract.»
An NHS spokesperson defended the contract, telling Sky News that the platform is «delivering huge benefits for patients and the NHS, joining up care, speeding up cancer diagnosis, and ensuring thousands of additional patients can be treated each month.» Palantir, the spokesperson said, was «appointed in line with public contract regulations and must only operate under the instruction of the NHS, with all access to data remaining under NHS control and strict contractual obligations protecting confidentiality.» File picture: PA
SOURCE
Por Michael Bunting
“I’m Michael Bunting, Communications Director with over 20 years of experience in corporate reputation, crisis management, and digital strategy. I have led teams in multinational companies and agencies, advised executives, and designed high-impact strategies. I am driven by transparency, innovation, and leveraging communication as a competitive advantage.”